nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—epilepsy syndrome	0.21	0.438	CbGaD
Cevimeline—CHRM1—epilepsy syndrome	0.196	0.409	CbGaD
Cevimeline—CYP2D6—epilepsy syndrome	0.0733	0.153	CbGaD
Cevimeline—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0193	0.0819	CbGbCtD
Cevimeline—CYP3A4—Trimethadione—epilepsy syndrome	0.0179	0.0762	CbGbCtD
Cevimeline—CYP3A4—Felbamate—epilepsy syndrome	0.0179	0.0762	CbGbCtD
Cevimeline—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0168	0.0716	CbGbCtD
Cevimeline—CYP2D6—Propofol—epilepsy syndrome	0.0159	0.0677	CbGbCtD
Cevimeline—CYP3A4—Clonazepam—epilepsy syndrome	0.0152	0.0648	CbGbCtD
Cevimeline—CYP3A4—Clobazam—epilepsy syndrome	0.0146	0.0621	CbGbCtD
Cevimeline—CYP3A4—Rufinamide—epilepsy syndrome	0.0124	0.0528	CbGbCtD
Cevimeline—CYP3A4—Carbamazepine—epilepsy syndrome	0.0121	0.0514	CbGbCtD
Cevimeline—CYP3A4—Primidone—epilepsy syndrome	0.0113	0.048	CbGbCtD
Cevimeline—CYP3A4—Phenytoin—epilepsy syndrome	0.0109	0.0461	CbGbCtD
Cevimeline—CYP3A4—Propofol—epilepsy syndrome	0.0101	0.043	CbGbCtD
Cevimeline—CYP3A4—Phenobarbital—epilepsy syndrome	0.00967	0.0411	CbGbCtD
Cevimeline—CYP3A4—Acetazolamide—epilepsy syndrome	0.00967	0.0411	CbGbCtD
Cevimeline—CYP3A4—Midazolam—epilepsy syndrome	0.00954	0.0405	CbGbCtD
Cevimeline—CYP3A4—Diazepam—epilepsy syndrome	0.00917	0.039	CbGbCtD
Cevimeline—CYP3A4—Zonisamide—epilepsy syndrome	0.00895	0.0381	CbGbCtD
Cevimeline—CYP3A4—Valproic Acid—epilepsy syndrome	0.00723	0.0307	CbGbCtD
Cevimeline—CYP3A4—Topiramate—epilepsy syndrome	0.00652	0.0277	CbGbCtD
Cevimeline—FMO1—forebrain—epilepsy syndrome	0.000574	0.119	CbGeAlD
Cevimeline—FMO1—head—epilepsy syndrome	0.000329	0.0683	CbGeAlD
Cevimeline—FMO1—nervous system—epilepsy syndrome	0.000312	0.0648	CbGeAlD
Cevimeline—FMO1—central nervous system—epilepsy syndrome	0.0003	0.0624	CbGeAlD
Cevimeline—CHRM1—forebrain—epilepsy syndrome	0.000264	0.0548	CbGeAlD
Cevimeline—CHRM1—telencephalon—epilepsy syndrome	0.000242	0.0504	CbGeAlD
Cevimeline—FMO1—brain—epilepsy syndrome	0.000238	0.0495	CbGeAlD
Cevimeline—CHRM3—forebrain—epilepsy syndrome	0.000236	0.049	CbGeAlD
Cevimeline—CYP2D6—hindbrain—epilepsy syndrome	0.000231	0.0479	CbGeAlD
Cevimeline—CHRM3—telencephalon—epilepsy syndrome	0.000217	0.0451	CbGeAlD
Cevimeline—CHRM1—head—epilepsy syndrome	0.000151	0.0314	CbGeAlD
Cevimeline—CHRM1—nervous system—epilepsy syndrome	0.000143	0.0298	CbGeAlD
Cevimeline—CHRM1—central nervous system—epilepsy syndrome	0.000138	0.0286	CbGeAlD
Cevimeline—CHRM3—head—epilepsy syndrome	0.000135	0.0281	CbGeAlD
Cevimeline—CYP2D6—brainstem—epilepsy syndrome	0.000132	0.0275	CbGeAlD
Cevimeline—CHRM3—nervous system—epilepsy syndrome	0.000128	0.0266	CbGeAlD
Cevimeline—CYP2D6—forebrain—epilepsy syndrome	0.000128	0.0265	CbGeAlD
Cevimeline—CHRM3—central nervous system—epilepsy syndrome	0.000123	0.0256	CbGeAlD
Cevimeline—CYP2D6—telencephalon—epilepsy syndrome	0.000117	0.0244	CbGeAlD
Cevimeline—CHRM1—brain—epilepsy syndrome	0.000109	0.0227	CbGeAlD
Cevimeline—CHRM3—brain—epilepsy syndrome	9.79e-05	0.0203	CbGeAlD
Cevimeline—CYP2D6—head—epilepsy syndrome	7.31e-05	0.0152	CbGeAlD
Cevimeline—CYP3A4—nervous system—epilepsy syndrome	7.04e-05	0.0146	CbGeAlD
Cevimeline—CYP2D6—nervous system—epilepsy syndrome	6.93e-05	0.0144	CbGeAlD
Cevimeline—CYP3A4—central nervous system—epilepsy syndrome	6.78e-05	0.0141	CbGeAlD
Cevimeline—CYP2D6—central nervous system—epilepsy syndrome	6.67e-05	0.0139	CbGeAlD
Cevimeline—CYP2D6—cerebellum—epilepsy syndrome	6.52e-05	0.0135	CbGeAlD
Cevimeline—CYP2D6—brain—epilepsy syndrome	5.3e-05	0.011	CbGeAlD
Cevimeline—Convulsion—Pregabalin—epilepsy syndrome	2.36e-05	0.000104	CcSEcCtD
Cevimeline—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.36e-05	0.000104	CcSEcCtD
Cevimeline—Headache—Vigabatrin—epilepsy syndrome	2.35e-05	0.000104	CcSEcCtD
Cevimeline—Hypertension—Pregabalin—epilepsy syndrome	2.35e-05	0.000103	CcSEcCtD
Cevimeline—Vomiting—Diazepam—epilepsy syndrome	2.35e-05	0.000103	CcSEcCtD
Cevimeline—Anorexia—Valproic Acid—epilepsy syndrome	2.34e-05	0.000103	CcSEcCtD
Cevimeline—Tremor—Gabapentin—epilepsy syndrome	2.34e-05	0.000103	CcSEcCtD
Cevimeline—Rash—Diazepam—epilepsy syndrome	2.33e-05	0.000103	CcSEcCtD
Cevimeline—Dermatitis—Diazepam—epilepsy syndrome	2.33e-05	0.000103	CcSEcCtD
Cevimeline—Visual impairment—Topiramate—epilepsy syndrome	2.33e-05	0.000102	CcSEcCtD
Cevimeline—Myalgia—Pregabalin—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Arthralgia—Pregabalin—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Chest pain—Pregabalin—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Dizziness—Zonisamide—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Headache—Diazepam—epilepsy syndrome	2.32e-05	0.000102	CcSEcCtD
Cevimeline—Anxiety—Pregabalin—epilepsy syndrome	2.31e-05	0.000102	CcSEcCtD
Cevimeline—Diarrhoea—Clonazepam—epilepsy syndrome	2.31e-05	0.000102	CcSEcCtD
Cevimeline—Anaemia—Gabapentin—epilepsy syndrome	2.31e-05	0.000102	CcSEcCtD
Cevimeline—Hypotension—Valproic Acid—epilepsy syndrome	2.3e-05	0.000101	CcSEcCtD
Cevimeline—Asthenia—Carbamazepine—epilepsy syndrome	2.3e-05	0.000101	CcSEcCtD
Cevimeline—Agitation—Gabapentin—epilepsy syndrome	2.3e-05	0.000101	CcSEcCtD
Cevimeline—Diarrhoea—Phenytoin—epilepsy syndrome	2.3e-05	0.000101	CcSEcCtD
Cevimeline—Discomfort—Pregabalin—epilepsy syndrome	2.29e-05	0.000101	CcSEcCtD
Cevimeline—Nausea—Fosphenytoin—epilepsy syndrome	2.29e-05	0.000101	CcSEcCtD
Cevimeline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.28e-05	0.0001	CcSEcCtD
Cevimeline—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.28e-05	0.0001	CcSEcCtD
Cevimeline—Vomiting—Felbamate—epilepsy syndrome	2.28e-05	0.0001	CcSEcCtD
Cevimeline—Pruritus—Carbamazepine—epilepsy syndrome	2.27e-05	9.97e-05	CcSEcCtD
Cevimeline—Rash—Felbamate—epilepsy syndrome	2.26e-05	9.93e-05	CcSEcCtD
Cevimeline—Eye disorder—Topiramate—epilepsy syndrome	2.26e-05	9.93e-05	CcSEcCtD
Cevimeline—Dermatitis—Felbamate—epilepsy syndrome	2.26e-05	9.92e-05	CcSEcCtD
Cevimeline—Malaise—Gabapentin—epilepsy syndrome	2.25e-05	9.91e-05	CcSEcCtD
Cevimeline—Tinnitus—Topiramate—epilepsy syndrome	2.25e-05	9.9e-05	CcSEcCtD
Cevimeline—Vertigo—Gabapentin—epilepsy syndrome	2.24e-05	9.87e-05	CcSEcCtD
Cevimeline—Headache—Felbamate—epilepsy syndrome	2.24e-05	9.87e-05	CcSEcCtD
Cevimeline—Confusional state—Pregabalin—epilepsy syndrome	2.24e-05	9.86e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.24e-05	9.86e-05	CcSEcCtD
Cevimeline—Flushing—Topiramate—epilepsy syndrome	2.24e-05	9.86e-05	CcSEcCtD
Cevimeline—Cardiac disorder—Topiramate—epilepsy syndrome	2.24e-05	9.86e-05	CcSEcCtD
Cevimeline—Syncope—Gabapentin—epilepsy syndrome	2.24e-05	9.86e-05	CcSEcCtD
Cevimeline—Leukopenia—Gabapentin—epilepsy syndrome	2.24e-05	9.84e-05	CcSEcCtD
Cevimeline—Dizziness—Clonazepam—epilepsy syndrome	2.23e-05	9.83e-05	CcSEcCtD
Cevimeline—Nausea—Vigabatrin—epilepsy syndrome	2.23e-05	9.82e-05	CcSEcCtD
Cevimeline—Vomiting—Zonisamide—epilepsy syndrome	2.23e-05	9.8e-05	CcSEcCtD
Cevimeline—Insomnia—Valproic Acid—epilepsy syndrome	2.22e-05	9.79e-05	CcSEcCtD
Cevimeline—Oedema—Pregabalin—epilepsy syndrome	2.22e-05	9.78e-05	CcSEcCtD
Cevimeline—Asthenia—Lamotrigine—epilepsy syndrome	2.22e-05	9.77e-05	CcSEcCtD
Cevimeline—Dizziness—Phenytoin—epilepsy syndrome	2.22e-05	9.76e-05	CcSEcCtD
Cevimeline—Rash—Zonisamide—epilepsy syndrome	2.21e-05	9.72e-05	CcSEcCtD
Cevimeline—Infection—Pregabalin—epilepsy syndrome	2.21e-05	9.72e-05	CcSEcCtD
Cevimeline—Paraesthesia—Valproic Acid—epilepsy syndrome	2.21e-05	9.72e-05	CcSEcCtD
Cevimeline—Palpitations—Gabapentin—epilepsy syndrome	2.21e-05	9.71e-05	CcSEcCtD
Cevimeline—Dermatitis—Zonisamide—epilepsy syndrome	2.21e-05	9.71e-05	CcSEcCtD
Cevimeline—Dizziness—Oxcarbazepine—epilepsy syndrome	2.21e-05	9.71e-05	CcSEcCtD
Cevimeline—Nausea—Diazepam—epilepsy syndrome	2.2e-05	9.67e-05	CcSEcCtD
Cevimeline—Loss of consciousness—Gabapentin—epilepsy syndrome	2.2e-05	9.66e-05	CcSEcCtD
Cevimeline—Headache—Zonisamide—epilepsy syndrome	2.2e-05	9.66e-05	CcSEcCtD
Cevimeline—Dyspnoea—Valproic Acid—epilepsy syndrome	2.19e-05	9.65e-05	CcSEcCtD
Cevimeline—Diarrhoea—Carbamazepine—epilepsy syndrome	2.19e-05	9.64e-05	CcSEcCtD
Cevimeline—Angiopathy—Topiramate—epilepsy syndrome	2.19e-05	9.64e-05	CcSEcCtD
Cevimeline—Pruritus—Lamotrigine—epilepsy syndrome	2.19e-05	9.63e-05	CcSEcCtD
Cevimeline—Shock—Pregabalin—epilepsy syndrome	2.19e-05	9.62e-05	CcSEcCtD
Cevimeline—Somnolence—Valproic Acid—epilepsy syndrome	2.19e-05	9.62e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Pregabalin—epilepsy syndrome	2.18e-05	9.59e-05	CcSEcCtD
Cevimeline—Cough—Gabapentin—epilepsy syndrome	2.18e-05	9.59e-05	CcSEcCtD
Cevimeline—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.18e-05	9.58e-05	CcSEcCtD
Cevimeline—Tachycardia—Pregabalin—epilepsy syndrome	2.17e-05	9.55e-05	CcSEcCtD
Cevimeline—Chills—Topiramate—epilepsy syndrome	2.17e-05	9.53e-05	CcSEcCtD
Cevimeline—Dyspepsia—Valproic Acid—epilepsy syndrome	2.16e-05	9.52e-05	CcSEcCtD
Cevimeline—Convulsion—Gabapentin—epilepsy syndrome	2.16e-05	9.52e-05	CcSEcCtD
Cevimeline—Skin disorder—Pregabalin—epilepsy syndrome	2.16e-05	9.5e-05	CcSEcCtD
Cevimeline—Hypertension—Gabapentin—epilepsy syndrome	2.16e-05	9.49e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.15e-05	9.46e-05	CcSEcCtD
Cevimeline—Vomiting—Clonazepam—epilepsy syndrome	2.15e-05	9.45e-05	CcSEcCtD
Cevimeline—Decreased appetite—Valproic Acid—epilepsy syndrome	2.14e-05	9.41e-05	CcSEcCtD
Cevimeline—Alopecia—Topiramate—epilepsy syndrome	2.13e-05	9.39e-05	CcSEcCtD
Cevimeline—Vomiting—Phenytoin—epilepsy syndrome	2.13e-05	9.38e-05	CcSEcCtD
Cevimeline—Rash—Clonazepam—epilepsy syndrome	2.13e-05	9.37e-05	CcSEcCtD
Cevimeline—Dermatitis—Clonazepam—epilepsy syndrome	2.13e-05	9.36e-05	CcSEcCtD
Cevimeline—Chest pain—Gabapentin—epilepsy syndrome	2.13e-05	9.36e-05	CcSEcCtD
Cevimeline—Arthralgia—Gabapentin—epilepsy syndrome	2.13e-05	9.36e-05	CcSEcCtD
Cevimeline—Myalgia—Gabapentin—epilepsy syndrome	2.13e-05	9.36e-05	CcSEcCtD
Cevimeline—Nausea—Felbamate—epilepsy syndrome	2.13e-05	9.36e-05	CcSEcCtD
Cevimeline—Vomiting—Oxcarbazepine—epilepsy syndrome	2.12e-05	9.34e-05	CcSEcCtD
Cevimeline—Fatigue—Valproic Acid—epilepsy syndrome	2.12e-05	9.33e-05	CcSEcCtD
Cevimeline—Anxiety—Gabapentin—epilepsy syndrome	2.12e-05	9.32e-05	CcSEcCtD
Cevimeline—Anorexia—Pregabalin—epilepsy syndrome	2.12e-05	9.32e-05	CcSEcCtD
Cevimeline—Dizziness—Carbamazepine—epilepsy syndrome	2.12e-05	9.32e-05	CcSEcCtD
Cevimeline—Diarrhoea—Lamotrigine—epilepsy syndrome	2.12e-05	9.32e-05	CcSEcCtD
Cevimeline—Headache—Clonazepam—epilepsy syndrome	2.12e-05	9.31e-05	CcSEcCtD
Cevimeline—Rash—Phenytoin—epilepsy syndrome	2.12e-05	9.31e-05	CcSEcCtD
Cevimeline—Dermatitis—Phenytoin—epilepsy syndrome	2.11e-05	9.3e-05	CcSEcCtD
Cevimeline—Rash—Oxcarbazepine—epilepsy syndrome	2.1e-05	9.26e-05	CcSEcCtD
Cevimeline—Constipation—Valproic Acid—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Pain—Valproic Acid—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Headache—Phenytoin—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Malnutrition—Topiramate—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Discomfort—Gabapentin—epilepsy syndrome	2.1e-05	9.25e-05	CcSEcCtD
Cevimeline—Headache—Oxcarbazepine—epilepsy syndrome	2.09e-05	9.2e-05	CcSEcCtD
Cevimeline—Nausea—Zonisamide—epilepsy syndrome	2.08e-05	9.16e-05	CcSEcCtD
Cevimeline—Hypotension—Pregabalin—epilepsy syndrome	2.08e-05	9.14e-05	CcSEcCtD
Cevimeline—Flatulence—Topiramate—epilepsy syndrome	2.07e-05	9.11e-05	CcSEcCtD
Cevimeline—Dysgeusia—Topiramate—epilepsy syndrome	2.06e-05	9.06e-05	CcSEcCtD
Cevimeline—Confusional state—Gabapentin—epilepsy syndrome	2.06e-05	9.04e-05	CcSEcCtD
Cevimeline—Dizziness—Lamotrigine—epilepsy syndrome	2.05e-05	9e-05	CcSEcCtD
Cevimeline—Oedema—Gabapentin—epilepsy syndrome	2.04e-05	8.97e-05	CcSEcCtD
Cevimeline—Vomiting—Carbamazepine—epilepsy syndrome	2.04e-05	8.96e-05	CcSEcCtD
Cevimeline—Back pain—Topiramate—epilepsy syndrome	2.03e-05	8.94e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.03e-05	8.92e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.03e-05	8.91e-05	CcSEcCtD
Cevimeline—Infection—Gabapentin—epilepsy syndrome	2.03e-05	8.91e-05	CcSEcCtD
Cevimeline—Muscle spasms—Topiramate—epilepsy syndrome	2.02e-05	8.89e-05	CcSEcCtD
Cevimeline—Rash—Carbamazepine—epilepsy syndrome	2.02e-05	8.88e-05	CcSEcCtD
Cevimeline—Dermatitis—Carbamazepine—epilepsy syndrome	2.02e-05	8.88e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.01e-05	8.85e-05	CcSEcCtD
Cevimeline—Insomnia—Pregabalin—epilepsy syndrome	2.01e-05	8.85e-05	CcSEcCtD
Cevimeline—Nausea—Clonazepam—epilepsy syndrome	2.01e-05	8.83e-05	CcSEcCtD
Cevimeline—Headache—Carbamazepine—epilepsy syndrome	2.01e-05	8.83e-05	CcSEcCtD
Cevimeline—Shock—Gabapentin—epilepsy syndrome	2.01e-05	8.83e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Gabapentin—epilepsy syndrome	2e-05	8.8e-05	CcSEcCtD
Cevimeline—Paraesthesia—Pregabalin—epilepsy syndrome	2e-05	8.78e-05	CcSEcCtD
Cevimeline—Thrombocytopenia—Gabapentin—epilepsy syndrome	2e-05	8.78e-05	CcSEcCtD
Cevimeline—Nausea—Phenytoin—epilepsy syndrome	1.99e-05	8.77e-05	CcSEcCtD
Cevimeline—Tachycardia—Gabapentin—epilepsy syndrome	1.99e-05	8.75e-05	CcSEcCtD
Cevimeline—Dyspnoea—Pregabalin—epilepsy syndrome	1.98e-05	8.72e-05	CcSEcCtD
Cevimeline—Nausea—Oxcarbazepine—epilepsy syndrome	1.98e-05	8.72e-05	CcSEcCtD
Cevimeline—Skin disorder—Gabapentin—epilepsy syndrome	1.98e-05	8.71e-05	CcSEcCtD
Cevimeline—Somnolence—Pregabalin—epilepsy syndrome	1.98e-05	8.7e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.97e-05	8.67e-05	CcSEcCtD
Cevimeline—Tremor—Topiramate—epilepsy syndrome	1.97e-05	8.66e-05	CcSEcCtD
Cevimeline—Vomiting—Lamotrigine—epilepsy syndrome	1.97e-05	8.66e-05	CcSEcCtD
Cevimeline—Urticaria—Valproic Acid—epilepsy syndrome	1.95e-05	8.6e-05	CcSEcCtD
Cevimeline—Rash—Lamotrigine—epilepsy syndrome	1.95e-05	8.59e-05	CcSEcCtD
Cevimeline—Ill-defined disorder—Topiramate—epilepsy syndrome	1.95e-05	8.58e-05	CcSEcCtD
Cevimeline—Dermatitis—Lamotrigine—epilepsy syndrome	1.95e-05	8.58e-05	CcSEcCtD
Cevimeline—Abdominal pain—Valproic Acid—epilepsy syndrome	1.94e-05	8.55e-05	CcSEcCtD
Cevimeline—Body temperature increased—Valproic Acid—epilepsy syndrome	1.94e-05	8.55e-05	CcSEcCtD
Cevimeline—Anorexia—Gabapentin—epilepsy syndrome	1.94e-05	8.55e-05	CcSEcCtD
Cevimeline—Anaemia—Topiramate—epilepsy syndrome	1.94e-05	8.55e-05	CcSEcCtD
Cevimeline—Headache—Lamotrigine—epilepsy syndrome	1.94e-05	8.53e-05	CcSEcCtD
Cevimeline—Decreased appetite—Pregabalin—epilepsy syndrome	1.93e-05	8.5e-05	CcSEcCtD
Cevimeline—Agitation—Topiramate—epilepsy syndrome	1.93e-05	8.5e-05	CcSEcCtD
Cevimeline—Fatigue—Pregabalin—epilepsy syndrome	1.92e-05	8.43e-05	CcSEcCtD
Cevimeline—Hypotension—Gabapentin—epilepsy syndrome	1.91e-05	8.38e-05	CcSEcCtD
Cevimeline—Nausea—Carbamazepine—epilepsy syndrome	1.9e-05	8.37e-05	CcSEcCtD
Cevimeline—Pain—Pregabalin—epilepsy syndrome	1.9e-05	8.37e-05	CcSEcCtD
Cevimeline—Constipation—Pregabalin—epilepsy syndrome	1.9e-05	8.37e-05	CcSEcCtD
Cevimeline—Malaise—Topiramate—epilepsy syndrome	1.9e-05	8.34e-05	CcSEcCtD
Cevimeline—Vertigo—Topiramate—epilepsy syndrome	1.89e-05	8.31e-05	CcSEcCtD
Cevimeline—Syncope—Topiramate—epilepsy syndrome	1.88e-05	8.29e-05	CcSEcCtD
Cevimeline—Leukopenia—Topiramate—epilepsy syndrome	1.88e-05	8.28e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.86e-05	8.17e-05	CcSEcCtD
Cevimeline—Palpitations—Topiramate—epilepsy syndrome	1.86e-05	8.17e-05	CcSEcCtD
Cevimeline—Loss of consciousness—Topiramate—epilepsy syndrome	1.85e-05	8.13e-05	CcSEcCtD
Cevimeline—Insomnia—Gabapentin—epilepsy syndrome	1.84e-05	8.11e-05	CcSEcCtD
Cevimeline—Nausea—Lamotrigine—epilepsy syndrome	1.84e-05	8.09e-05	CcSEcCtD
Cevimeline—Cough—Topiramate—epilepsy syndrome	1.83e-05	8.07e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Pregabalin—epilepsy syndrome	1.83e-05	8.06e-05	CcSEcCtD
Cevimeline—Paraesthesia—Gabapentin—epilepsy syndrome	1.83e-05	8.05e-05	CcSEcCtD
Cevimeline—Convulsion—Topiramate—epilepsy syndrome	1.82e-05	8.01e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.82e-05	8e-05	CcSEcCtD
Cevimeline—Dyspnoea—Gabapentin—epilepsy syndrome	1.82e-05	8e-05	CcSEcCtD
Cevimeline—Hypertension—Topiramate—epilepsy syndrome	1.81e-05	7.98e-05	CcSEcCtD
Cevimeline—Somnolence—Gabapentin—epilepsy syndrome	1.81e-05	7.97e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.81e-05	7.97e-05	CcSEcCtD
Cevimeline—Dyspepsia—Gabapentin—epilepsy syndrome	1.79e-05	7.9e-05	CcSEcCtD
Cevimeline—Arthralgia—Topiramate—epilepsy syndrome	1.79e-05	7.87e-05	CcSEcCtD
Cevimeline—Chest pain—Topiramate—epilepsy syndrome	1.79e-05	7.87e-05	CcSEcCtD
Cevimeline—Myalgia—Topiramate—epilepsy syndrome	1.79e-05	7.87e-05	CcSEcCtD
Cevimeline—Anxiety—Topiramate—epilepsy syndrome	1.78e-05	7.85e-05	CcSEcCtD
Cevimeline—Decreased appetite—Gabapentin—epilepsy syndrome	1.77e-05	7.8e-05	CcSEcCtD
Cevimeline—Discomfort—Topiramate—epilepsy syndrome	1.77e-05	7.78e-05	CcSEcCtD
Cevimeline—Urticaria—Pregabalin—epilepsy syndrome	1.77e-05	7.77e-05	CcSEcCtD
Cevimeline—Asthenia—Valproic Acid—epilepsy syndrome	1.76e-05	7.76e-05	CcSEcCtD
Cevimeline—Fatigue—Gabapentin—epilepsy syndrome	1.76e-05	7.73e-05	CcSEcCtD
Cevimeline—Abdominal pain—Pregabalin—epilepsy syndrome	1.76e-05	7.73e-05	CcSEcCtD
Cevimeline—Body temperature increased—Pregabalin—epilepsy syndrome	1.76e-05	7.73e-05	CcSEcCtD
Cevimeline—Pain—Gabapentin—epilepsy syndrome	1.74e-05	7.67e-05	CcSEcCtD
Cevimeline—Constipation—Gabapentin—epilepsy syndrome	1.74e-05	7.67e-05	CcSEcCtD
Cevimeline—Pruritus—Valproic Acid—epilepsy syndrome	1.74e-05	7.66e-05	CcSEcCtD
Cevimeline—Confusional state—Topiramate—epilepsy syndrome	1.73e-05	7.61e-05	CcSEcCtD
Cevimeline—Oedema—Topiramate—epilepsy syndrome	1.72e-05	7.55e-05	CcSEcCtD
Cevimeline—Infection—Topiramate—epilepsy syndrome	1.7e-05	7.5e-05	CcSEcCtD
Cevimeline—Shock—Topiramate—epilepsy syndrome	1.69e-05	7.42e-05	CcSEcCtD
Cevimeline—Diarrhoea—Valproic Acid—epilepsy syndrome	1.68e-05	7.4e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Topiramate—epilepsy syndrome	1.68e-05	7.4e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Gabapentin—epilepsy syndrome	1.68e-05	7.39e-05	CcSEcCtD
Cevimeline—Thrombocytopenia—Topiramate—epilepsy syndrome	1.68e-05	7.39e-05	CcSEcCtD
Cevimeline—Tachycardia—Topiramate—epilepsy syndrome	1.67e-05	7.37e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.67e-05	7.34e-05	CcSEcCtD
Cevimeline—Skin disorder—Topiramate—epilepsy syndrome	1.67e-05	7.33e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Topiramate—epilepsy syndrome	1.66e-05	7.3e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Pregabalin—epilepsy syndrome	1.64e-05	7.21e-05	CcSEcCtD
Cevimeline—Anorexia—Topiramate—epilepsy syndrome	1.63e-05	7.19e-05	CcSEcCtD
Cevimeline—Dizziness—Valproic Acid—epilepsy syndrome	1.63e-05	7.16e-05	CcSEcCtD
Cevimeline—Urticaria—Gabapentin—epilepsy syndrome	1.62e-05	7.13e-05	CcSEcCtD
Cevimeline—Abdominal pain—Gabapentin—epilepsy syndrome	1.61e-05	7.09e-05	CcSEcCtD
Cevimeline—Body temperature increased—Gabapentin—epilepsy syndrome	1.61e-05	7.09e-05	CcSEcCtD
Cevimeline—Hypotension—Topiramate—epilepsy syndrome	1.6e-05	7.05e-05	CcSEcCtD
Cevimeline—Asthenia—Pregabalin—epilepsy syndrome	1.6e-05	7.02e-05	CcSEcCtD
Cevimeline—Pruritus—Pregabalin—epilepsy syndrome	1.57e-05	6.92e-05	CcSEcCtD
Cevimeline—Vomiting—Valproic Acid—epilepsy syndrome	1.56e-05	6.88e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.56e-05	6.88e-05	CcSEcCtD
Cevimeline—Insomnia—Topiramate—epilepsy syndrome	1.55e-05	6.83e-05	CcSEcCtD
Cevimeline—Rash—Valproic Acid—epilepsy syndrome	1.55e-05	6.82e-05	CcSEcCtD
Cevimeline—Dermatitis—Valproic Acid—epilepsy syndrome	1.55e-05	6.82e-05	CcSEcCtD
Cevimeline—Headache—Valproic Acid—epilepsy syndrome	1.54e-05	6.78e-05	CcSEcCtD
Cevimeline—Paraesthesia—Topiramate—epilepsy syndrome	1.54e-05	6.78e-05	CcSEcCtD
Cevimeline—Dyspnoea—Topiramate—epilepsy syndrome	1.53e-05	6.73e-05	CcSEcCtD
Cevimeline—Somnolence—Topiramate—epilepsy syndrome	1.52e-05	6.71e-05	CcSEcCtD
Cevimeline—Diarrhoea—Pregabalin—epilepsy syndrome	1.52e-05	6.69e-05	CcSEcCtD
Cevimeline—Dyspepsia—Topiramate—epilepsy syndrome	1.51e-05	6.64e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Gabapentin—epilepsy syndrome	1.5e-05	6.61e-05	CcSEcCtD
Cevimeline—Decreased appetite—Topiramate—epilepsy syndrome	1.49e-05	6.56e-05	CcSEcCtD
Cevimeline—Fatigue—Topiramate—epilepsy syndrome	1.48e-05	6.51e-05	CcSEcCtD
Cevimeline—Dizziness—Pregabalin—epilepsy syndrome	1.47e-05	6.47e-05	CcSEcCtD
Cevimeline—Pain—Topiramate—epilepsy syndrome	1.47e-05	6.45e-05	CcSEcCtD
Cevimeline—Constipation—Topiramate—epilepsy syndrome	1.47e-05	6.45e-05	CcSEcCtD
Cevimeline—Asthenia—Gabapentin—epilepsy syndrome	1.46e-05	6.44e-05	CcSEcCtD
Cevimeline—Nausea—Valproic Acid—epilepsy syndrome	1.46e-05	6.43e-05	CcSEcCtD
Cevimeline—Pruritus—Gabapentin—epilepsy syndrome	1.44e-05	6.35e-05	CcSEcCtD
Cevimeline—Vomiting—Pregabalin—epilepsy syndrome	1.41e-05	6.22e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Topiramate—epilepsy syndrome	1.41e-05	6.22e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.4e-05	6.17e-05	CcSEcCtD
Cevimeline—Rash—Pregabalin—epilepsy syndrome	1.4e-05	6.17e-05	CcSEcCtD
Cevimeline—Dermatitis—Pregabalin—epilepsy syndrome	1.4e-05	6.16e-05	CcSEcCtD
Cevimeline—Diarrhoea—Gabapentin—epilepsy syndrome	1.39e-05	6.14e-05	CcSEcCtD
Cevimeline—Headache—Pregabalin—epilepsy syndrome	1.39e-05	6.13e-05	CcSEcCtD
Cevimeline—Urticaria—Topiramate—epilepsy syndrome	1.36e-05	6e-05	CcSEcCtD
Cevimeline—Abdominal pain—Topiramate—epilepsy syndrome	1.36e-05	5.97e-05	CcSEcCtD
Cevimeline—Body temperature increased—Topiramate—epilepsy syndrome	1.36e-05	5.97e-05	CcSEcCtD
Cevimeline—Dizziness—Gabapentin—epilepsy syndrome	1.35e-05	5.93e-05	CcSEcCtD
Cevimeline—Nausea—Pregabalin—epilepsy syndrome	1.32e-05	5.81e-05	CcSEcCtD
Cevimeline—Vomiting—Gabapentin—epilepsy syndrome	1.3e-05	5.7e-05	CcSEcCtD
Cevimeline—Rash—Gabapentin—epilepsy syndrome	1.29e-05	5.66e-05	CcSEcCtD
Cevimeline—Dermatitis—Gabapentin—epilepsy syndrome	1.28e-05	5.65e-05	CcSEcCtD
Cevimeline—Headache—Gabapentin—epilepsy syndrome	1.28e-05	5.62e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Topiramate—epilepsy syndrome	1.26e-05	5.56e-05	CcSEcCtD
Cevimeline—Asthenia—Topiramate—epilepsy syndrome	1.23e-05	5.41e-05	CcSEcCtD
Cevimeline—Pruritus—Topiramate—epilepsy syndrome	1.21e-05	5.34e-05	CcSEcCtD
Cevimeline—Nausea—Gabapentin—epilepsy syndrome	1.21e-05	5.33e-05	CcSEcCtD
Cevimeline—Diarrhoea—Topiramate—epilepsy syndrome	1.17e-05	5.16e-05	CcSEcCtD
Cevimeline—Dizziness—Topiramate—epilepsy syndrome	1.13e-05	4.99e-05	CcSEcCtD
Cevimeline—Vomiting—Topiramate—epilepsy syndrome	1.09e-05	4.8e-05	CcSEcCtD
Cevimeline—Rash—Topiramate—epilepsy syndrome	1.08e-05	4.76e-05	CcSEcCtD
Cevimeline—Dermatitis—Topiramate—epilepsy syndrome	1.08e-05	4.75e-05	CcSEcCtD
Cevimeline—Headache—Topiramate—epilepsy syndrome	1.07e-05	4.73e-05	CcSEcCtD
Cevimeline—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.03e-05	0.000196	CbGpPWpGaD
Cevimeline—Nausea—Topiramate—epilepsy syndrome	1.02e-05	4.48e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.02e-05	0.000193	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.01e-05	0.000193	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.01e-05	0.000192	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.01e-05	0.000192	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.01e-05	0.000192	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.01e-05	0.000191	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	9.99e-06	0.00019	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	9.98e-06	0.000189	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	9.98e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	9.98e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	9.98e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	9.98e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	9.95e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	9.95e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	9.95e-06	0.000189	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	9.77e-06	0.000185	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	9.75e-06	0.000185	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	9.72e-06	0.000184	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	9.71e-06	0.000184	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	9.68e-06	0.000184	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADSL—epilepsy syndrome	9.57e-06	0.000182	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—COX3—epilepsy syndrome	9.52e-06	0.000181	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	9.44e-06	0.000179	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	9.41e-06	0.000179	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GLUL—epilepsy syndrome	9.39e-06	0.000178	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	9.31e-06	0.000177	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	9.28e-06	0.000176	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	9.21e-06	0.000175	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	9.16e-06	0.000174	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	9.13e-06	0.000173	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PFKL—epilepsy syndrome	9.03e-06	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	9.03e-06	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	9.03e-06	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	9.03e-06	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	9.03e-06	0.000171	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	9.02e-06	0.000171	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	8.84e-06	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	8.81e-06	0.000167	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	8.65e-06	0.000164	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.65e-06	0.000164	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	8.63e-06	0.000164	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.62e-06	0.000164	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	8.62e-06	0.000164	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	8.58e-06	0.000163	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—BCHE—epilepsy syndrome	8.55e-06	0.000162	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	8.43e-06	0.00016	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.43e-06	0.00016	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	8.41e-06	0.00016	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	8.41e-06	0.00016	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AQP1—epilepsy syndrome	8.37e-06	0.000159	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NEU1—epilepsy syndrome	8.26e-06	0.000157	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—UPB1—epilepsy syndrome	8.26e-06	0.000157	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ATIC—epilepsy syndrome	8.26e-06	0.000157	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	8.21e-06	0.000156	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	8.18e-06	0.000155	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	8.15e-06	0.000155	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	8.14e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	8.14e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	8.14e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	8.14e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	8.14e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	8.11e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	8.11e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	8.11e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	8.11e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	8.11e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLCB1—epilepsy syndrome	8.06e-06	0.000153	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TH—epilepsy syndrome	8.04e-06	0.000153	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	8.03e-06	0.000152	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	8e-06	0.000152	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.95e-06	0.000151	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	7.85e-06	0.000149	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	7.83e-06	0.000149	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.68e-06	0.000146	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.68e-06	0.000146	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.58e-06	0.000144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	7.57e-06	0.000144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	7.57e-06	0.000144	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	7.56e-06	0.000144	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	7.56e-06	0.000144	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.56e-06	0.000143	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	7.54e-06	0.000143	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	7.54e-06	0.000143	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	7.45e-06	0.000141	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	7.43e-06	0.000141	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	7.36e-06	0.00014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	7.36e-06	0.00014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SST—epilepsy syndrome	7.36e-06	0.00014	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	7.33e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	7.33e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SST—epilepsy syndrome	7.33e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	7.29e-06	0.000138	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	7.27e-06	0.000138	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.22e-06	0.000137	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.2e-06	0.000137	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.18e-06	0.000136	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	7.17e-06	0.000136	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	7.15e-06	0.000136	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—epilepsy syndrome	7.12e-06	0.000135	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.02e-06	0.000133	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.92e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	6.92e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	6.91e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	6.9e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	6.9e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.89e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	6.89e-06	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	6.86e-06	0.00013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.86e-06	0.00013	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.84e-06	0.00013	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.84e-06	0.00013	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	6.84e-06	0.00013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	6.79e-06	0.000129	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	6.79e-06	0.000129	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	6.77e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	6.77e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	6.77e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	6.74e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—epilepsy syndrome	6.71e-06	0.000127	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	6.62e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAT—epilepsy syndrome	6.62e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	6.6e-06	0.000125	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.53e-06	0.000124	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.53e-06	0.000124	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCB1—epilepsy syndrome	6.44e-06	0.000122	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	6.43e-06	0.000122	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	6.41e-06	0.000122	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.39e-06	0.000121	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	6.31e-06	0.00012	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	6.29e-06	0.000119	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	6.27e-06	0.000119	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.26e-06	0.000119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	6.25e-06	0.000119	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	6.17e-06	0.000117	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	6.17e-06	0.000117	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	6.15e-06	0.000117	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	6.14e-06	0.000116	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.14e-06	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	6.12e-06	0.000116	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.02e-06	0.000114	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	6.01e-06	0.000114	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GPX1—epilepsy syndrome	5.98e-06	0.000114	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	5.97e-06	0.000113	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	5.83e-06	0.000111	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	5.81e-06	0.00011	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.77e-06	0.00011	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.76e-06	0.000109	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	5.75e-06	0.000109	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	5.74e-06	0.000109	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.63e-06	0.000107	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	5.58e-06	0.000106	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	5.56e-06	0.000105	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.47e-06	0.000104	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	5.27e-06	0.0001	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	5.26e-06	9.98e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AGT—epilepsy syndrome	5.25e-06	9.96e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—epilepsy syndrome	5.14e-06	9.76e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	5.13e-06	9.74e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	5.13e-06	9.73e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	5.11e-06	9.7e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BCHE—epilepsy syndrome	5.11e-06	9.7e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	5.11e-06	9.7e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	5.1e-06	9.68e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	5.09e-06	9.67e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	5.08e-06	9.65e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.95e-06	9.39e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.95e-06	9.39e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.93e-06	9.35e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.91e-06	9.33e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	4.88e-06	9.25e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	4.87e-06	9.25e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	4.86e-06	9.22e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	4.82e-06	9.15e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TH—epilepsy syndrome	4.8e-06	9.12e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.74e-06	9e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	4.73e-06	8.97e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.64e-06	8.81e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	4.62e-06	8.78e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—epilepsy syndrome	4.42e-06	8.38e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	4.41e-06	8.37e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	4.4e-06	8.36e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	4.39e-06	8.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	4.39e-06	8.33e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	4.31e-06	8.19e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	4.3e-06	8.16e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	4.23e-06	8.02e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	4.21e-06	7.99e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.07e-06	7.72e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.05e-06	7.7e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.05e-06	7.69e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.04e-06	7.66e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.03e-06	7.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—epilepsy syndrome	4.03e-06	7.64e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	4.01e-06	7.61e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.96e-06	7.51e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.93e-06	7.46e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.91e-06	7.41e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.85e-06	7.31e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	3.71e-06	7.03e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	3.69e-06	7.01e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.63e-06	6.88e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.61e-06	6.86e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.58e-06	6.79e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.52e-06	6.69e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.52e-06	6.69e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.36e-06	6.37e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.34e-06	6.34e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.28e-06	6.22e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.27e-06	6.2e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.19e-06	6.05e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.15e-06	5.98e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TH—epilepsy syndrome	3.14e-06	5.96e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.14e-06	5.96e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.07e-06	5.84e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.04e-06	5.77e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.03e-06	5.75e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.98e-06	5.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.97e-06	5.64e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.77e-06	5.26e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.76e-06	5.24e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.74e-06	5.21e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.73e-06	5.19e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.66e-06	5.06e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.66e-06	5.04e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.64e-06	5.01e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.62e-06	4.98e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.59e-06	4.92e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.59e-06	4.91e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.58e-06	4.9e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.52e-06	4.78e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.51e-06	4.77e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.51e-06	4.76e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.41e-06	4.57e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.39e-06	4.54e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.38e-06	4.52e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.34e-06	4.44e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.33e-06	4.42e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.32e-06	4.4e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.11e-06	4e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.05e-06	3.89e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.01e-06	3.82e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.77e-06	3.36e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.73e-06	3.28e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.57e-06	2.99e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.49e-06	2.82e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.48e-06	2.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.38e-06	2.61e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.06e-06	2.01e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.92e-07	1.31e-05	CbGpPWpGaD
